The current targeted therapy for POB is similar to that for common osteosarcoma and focuses on the following targets: The mammalian target of rapamycin (mTOR) protein can hinder the growth of tumors by controlling the cell cycle of tumor cells. Here, MTOR is linked to osteosarcoma.